Hepatitis B virus mRNAs functionally sequester let-7a and enhance hepatocellular carcinoma

Area of Science:

• Molecular Biology
• Virology
• Oncology

Background:

• Hepatitis B virus (HBV) infection is a major cause of hepatocellular carcinoma (HCC).
• The role of viral mRNAs in HBV-induced hepatocarcinogenesis remains largely unknown.
• MicroRNAs (miRNAs) are critical regulators of gene expression implicated in cancer.

Purpose of the Study:

• To investigate the impact of HBV mRNAs on cellular gene expression and miRNA regulation.
• To determine the mechanism by which HBV contributes to liver cancer development.

Main Methods:

• Bioinformatic analysis (miRNA target prediction, whole genome expression analysis).
• In vitro studies (transfection, cell culture assays).
• In vivo studies (animal models).
• Analysis of patient liver samples.

Main Results:

• HBV pre-C/C mRNA upregulates let-7a target genes by sequestering let-7a via a complementary region in viral mRNAs.
• HBV infection reduces let-7a levels and AGO2 binding, leading to de-repression of let-7a targets like c-myc and K-RAS.
• Decreased hepatic let-7a levels correlate with intrahepatic pre-S2 mRNA in HCC patients.
• Inhibition of let-7a by HBV mRNAs enhances HCC cell proliferation and tumor growth in vitro and in vivo.

Conclusions:

• HBV mRNAs possess oncogenic potential by actively suppressing tumor-suppressive miRNAs like let-7a.
• This viral miRNA sequestration mechanism contributes to HBV-driven hepatocarcinogenesis.
• Targeting this viral mechanism could offer new therapeutic strategies for HBV-related HCC.